| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | Michael Gibney Pharma Voice | This biotech aims to expand the CRISPR toolkit for more disease targets in the liver and brain - 5 months ago Bristol Myers’ commercial chief on the industry’s ‘seismic’ changes over 27 years and what’s coming next - 5 months ago Real Chemistry’s CEO on biopharma’s outlook in 2024 - 5 months ago The head of AstraZeneca’s new digital health spinoff on how the pharma is leveraging tech - 6 months ago AstraZeneca showed the pandemic isn’t over for immunocompromised patients. What’s next? - 6 months ago A new delivery method muscling its way into the RNA space - 6 months ago Red Jacket: Dr. Jeremy Levin, a transformational leader - 7 months ago Pfizer’s new shot approval adds to a growing vaccine prowess - 7 months ago The PharmaVoice 100: Rare disease warriors - 7 months ago The PharmaVoice 100: Cancer care visionaries - 8 months ago The PharmaVoice 100: Trailblazers - 8 months ago |
Michael Gibney
Pharma Voice